Value of CEUS for early diagnosis of cirrhosis with small liver cancer
超声造影对肝硬化合并小肝癌的早期诊断价值

摘要

目的 对肝硬化合并小肝癌早期患者接受超声造影诊断的临床价值进行观察。方法 观察对象为我院收治80例肝硬化合并小肝癌早期患者，纳入时间为2022年5月～2023年5月，利用随机数表法，分为常规组、观察组，各40例。常规组患者接受增强CT检查的方式；观察组患者接受超声造影诊断的方式；对比两组患者的诊断准确率。结果 观察组的诊断准确率为97.50%，常规组的诊断准确率为82.50%，差异有统计学意义（P＜0.05）。结论 在诊断肝硬化合并小肝癌早期患者的时候，应用超声造影诊断的方式，拥有显著的诊断准确率，保证治疗措施的有效性，拥有应用在临床中的价值。

Abstract

Objective To observe the clinical value of CEUS diagnosis in patients with small liver cancer.
Methods The observation objects were 80 patients with small liver cancer admitted to our hospital, and the inclusion time was from May 2022 to May 2023. By random number table, 40 cases were divided into routine group and observation group. The enhanced CT test in the conventional group; the diagnostic accuracy of the two groups.
Results The diagnostic accuracy of the observation group was 97.50% and the conventional group was 82.50%, significantly (P 0.05).
Conclusion   In the diagnosis of cirrhosis patients with small liver cancer, the application of contrast ultrasound diagnosis has significant diagnostic accuracy, ensures the effectiveness of treatment measures, and has the value of application in clinical practice.